Stocktoria
ANI PHARMACEUTICALS INC ANIP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2000-05-04
ANI PHARMACEUTICALS INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $883.4M | $614.4M | $486.8M | $316.4M | $216.1M |
| R&D expense | $51.7M | $44.6M | $34.3M | $22.3M | $11.4M |
| SG&A expense | $317.7M | $249.6M | $161.7M | $124.0M | $84.3M |
| Operating income | $111.1M | $584,000 | $47.0M | -$35.3M | -$39.8M |
| Income tax | $17.5M | -$3.7M | $1.1M | -$14.8M | -$13.5M |
| Net income | $78.3M | -$18.5M | $18.8M | -$47.9M | -$42.6M |
| EPS (diluted) | $3.32 | $-1.04 | $0.85 | $-3.05 | $-3.40 |
| Operating cash flow | $185.2M | $64.0M | $119.0M | -$31.2M | $3.3M |
| Free cash flow | $171.4M | $47.8M | $110.1M | -$40.1M | $765,000 |
| Cash & equivalents | $285.6M | $144.9M | $221.1M | $48.2M | $100.3M |
| Inventory | $143.1M | $136.8M | $111.2M | $105.4M | $81.7M |
| Total assets | $1.4B | $1.3B | $904.4M | $760.1M | $771.6M |
| Total liabilities | $899.7M | $855.9M | $446.8M | $421.5M | $412.9M |
| Shareholders' equity | $540.7M | $403.7M | $432.7M | $313.7M | $333.9M |
Source: SEC EDGAR filings · CIK 0001023024 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.